Phenomic is developing a platform that uses deep learning to systematically target chemotherapy resistance – an event which underpins 90% of all cancer treatment failures and accounts for millions of annual deaths worldwide. The deep learning models being created by the company today will eventually be used to develop novel biomarkers and therapeutics to fight against cancer.